RECORDREFERENCE OUTLINE

Central Laboratory Qualification Record

Qualification record assessing a central laboratory against the trial you are running rather than its brochure: the specific assays and matrices in scope, accreditation verified against the schedule rather than the certificate, empirical cross-site comparability, logistics tested with real shipments before the trial, data transfer and reconciliation agreed in writing, and escalation with an audit before commitment. Maps to WHO GCLP (2009) and EMA/INS/GCP/532137/2010.

What a template is not

A template is a document baseline to adapt inside your own quality system. SPEQ does not approve, validate, or take responsibility for what you issue from it, and using one is not evidence of compliance.

CHECKING ACCESS

Checking your Professional access…

REGULATIONS MAPPED
WHO GCLP (2009)EMA/INS/GCP/532137/2010
DOCUMENT TYPE
Record
LAST UPDATED
August 2026
PURPOSE

A central laboratory promises comparability across every region a trial runs in. Qualification establishes whether that promise holds for your assays, your matrices and your logistics — sponsors who qualify the organisation rather than the specific service discover the gap when one region behaves differently. Whether the comparability data is adequate for your endpoints is the sponsor’s determination, and it cannot be delegated to the laboratory.

What's Inside

The specific assays, matrices, regions and facilities in scope, named rather than described generally
Accreditation verified against the schedule of methods, because a certificate confirms only that some scope exists
Empirical cross-site comparability data, including units, reference ranges and how discrepant results were resolved
Logistics tested with real shipments on the real routes, including the ones crossing a border
Data transfer specification with formats, identifiers and the reconciliation cadence agreed in writing
Escalation events and notification times — what the laboratory must tell you, and how fast
Audit record and the findings accepted before commitment, with the re-audit triggers named

How to Use It

1Qualify the specific assays and matrices you will run, not the organisation; a qualified vendor is not a qualified assay
2Read the accreditation schedule rather than the certificate — accreditation is granted per method and per matrix, and yours may sit outside it
3Establish comparability empirically across the regional facilities; sites assumed harmonised produce differences that later read as treatment effects
4Test logistics with real shipments before enrolment, including customs routes, because a route fails in ways a plan cannot show
5Agree the data transfer specification and reconcile on an ongoing cadence, not at database lock when discrepancies are least fixable
6Audit before commitment and name the events that trigger re-audit, so the qualification does not quietly age out
DOCUMENT CONTENTS

The full section structure of this template — every section and sub-section, so you can use it as a baseline for your own site document.

Document Control
Document InformationApproval SignaturesRevision HistoryDistribution List
1What You Are Qualifying It For
2Accreditation Scope, Not the Certificate
3Cross-Site Comparability
4Logistics Tested Before the Trial
5Data Transfer and Reconciliation
6Escalation and Audit
REGULATORY CONTEXT

WHO Good Clinical Laboratory Practice (2009) sets the quality expectations for laboratories generating data in clinical trials, and the EMA reflection paper EMA/INS/GCP/532137/2010 addresses sponsor oversight of laboratories used in trials, including contracted ones. Neither qualifies a laboratory for you, defines adequate comparability for your endpoints, or decides which regional facilities you may use. Those determinations stay with the sponsor, who remains accountable for the data. The qualification structure here is SPEQ practitioner synthesis, not an accreditation or an endorsement.

MAPPED STANDARDS
WHO GCLP (2009)EMA/INS/GCP/532137/2010
Browse the standards catalog →